Literature DB >> 22722650

Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts.

Anne Casset1, Adriano Mari, Ashok Purohit, Yvonne Resch, Margit Weghofer, Rosetta Ferrara, Wayne R Thomas, Claudia Alessandri, Kuan-Wei Chen, Frédéric de Blay, Rudolf Valenta, Susanne Vrtala.   

Abstract

BACKGROUND: Diagnosis and immunotherapy of house-dust mite (HDM) allergy is still based on natural allergen extracts. The aim of this study was to analyze commercially available Dermatophagoides pteronyssinus extracts from different manufacturers regarding allergen composition and content and whether variations may affect their allergenic activity.
METHODS: Antibodies specific for several D. pteronyssinus allergens (Der p 1, 2, 5, 7, 10 and 21) were used to analyze extracts from 10 different manufacturers by immunoblotting. Sandwich ELISAs were used to quantify Der p 1 and Der p 2 in the extracts. Mite-allergic patients (n = 45) were skin-tested with the extracts and tested for immunoglobulin E (IgE) reactivity to a panel of 10 mite allergens (Der p 1, 2, 4, 5, 7, 8, 10, 14, 20 and 21) by dot blot.
RESULTS: Only Der p 1 and Der p 2 were detected in all extracts but their concentrations and ratios showed high variability (Der p 1: 6.0-40.8 µg ml(-1); Der p 2: 1.7-45.0 µg ml(-1)). At least 1 out of 4 allergens (i.e. Der p 5, 7, 10 and 21) was not detected in 8 of the studied extracts. Mite-allergic subjects showed different IgE reactivity profiles to the individual mite allergens, the extracts showed different allergenic activity in skin-prick tests and false-negative results.
CONCLUSIONS: Commercially available D. pteronyssinus extracts lack important allergens, show great variability regarding allergen composition and content and some gave false-negative diagnostic test results in certain patients.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722650      PMCID: PMC4594775          DOI: 10.1159/000337654

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  44 in total

1.  Recombinant spiked allergen extract.

Authors:  M Lundberg; Z Chen; H P Rihs; K Wrangsjö
Journal:  Allergy       Date:  2001-08       Impact factor: 13.146

Review 2.  Quality assurance and standardization of allergy extracts in allergy practice.

Authors:  C E Reed; J W Yunginger; R Evans
Journal:  J Allergy Clin Immunol       Date:  1989-07       Impact factor: 10.793

3.  Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system.

Authors:  L Vogel; D Lüttkopf; L Hatahet; D Haustein; S Vieths
Journal:  Allergy       Date:  2005-08       Impact factor: 13.146

Review 4.  Pyroglyphid house dust mite allergens.

Authors:  Wayne Robert Thomas; Tatjana Katharina Heinrich; Wendy-Anne Smith; Belinda Joy Hales
Journal:  Protein Pept Lett       Date:  2007       Impact factor: 1.890

5.  Sensitisation to the lipid-binding apolipophorin allergen Der p 14 and the peptide Mag-1.

Authors:  M J Epton; R J Dilworth; W Smith; W R Thomas
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

6.  Reproducibility of skin prick testing with allergen extracts from different manufacturers.

Authors:  I Eichler; M Götz; R Jarisch; H G Eichler; R Moss
Journal:  Allergy       Date:  1988-08       Impact factor: 13.146

7.  A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.

Authors:  Birgit Linhart; Arnulf Hartl; Beatrice Jahn-Schmid; Petra Verdino; Walter Keller; Maria-Theresa Krauth; Peter Valent; Friedrich Horak; Ursula Wiedermann; Josef Thalhamer; Christof Ebner; Dietrich Kraft; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2005-05       Impact factor: 10.793

8.  Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy.

Authors:  Y Resch; M Weghofer; S Seiberler; F Horak; S Scheiblhofer; B Linhart; I Swoboda; W R Thomas; J Thalhamer; R Valenta; S Vrtala
Journal:  Clin Exp Allergy       Date:  2011-06-29       Impact factor: 5.018

9.  Comparison of the levels of the major allergens Der p I and Der p II in standardized extracts of the house dust mite, Dermatophagoides pteronyssinus.

Authors:  C H Meyer; J F Bond; M S Chen; M T Kasaian
Journal:  Clin Exp Allergy       Date:  1994-11       Impact factor: 5.018

10.  Influence of mite growth culture phases on the biological standardization of allergenic extracts.

Authors:  E Eraso; J Martínez; P García-Ortega; A Martínez; R Palacios; R Cisterna; J A Guisantes
Journal:  J Investig Allergol Clin Immunol       Date:  1998 Jul-Aug       Impact factor: 4.333

View more
  52 in total

Review 1.  Standardization and Regulation of Allergen Products in the European Union.

Authors:  Julia Zimmer; Stefan Vieths; Susanne Kaul
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 2.  WHO/IUIS Allergen Nomenclature: Providing a common language.

Authors:  Anna Pomés; Janet M Davies; Gabriele Gadermaier; Christiane Hilger; Thomas Holzhauser; Jonas Lidholm; Andreas L Lopata; Geoffrey A Mueller; Andreas Nandy; Christian Radauer; Sanny K Chan; Uta Jappe; Jörg Kleine-Tebbe; Wayne R Thomas; Martin D Chapman; Marianne van Hage; Ronald van Ree; Stefan Vieths; Monika Raulf; Richard E Goodman
Journal:  Mol Immunol       Date:  2018-04-04       Impact factor: 4.407

Review 3.  Natural Evolution of IgE Responses to Mite Allergens and Relationship to Progression of Allergic Disease: a Review.

Authors:  Daniela Posa; Stephanie Hofmaier; Stefania Arasi; Paolo Maria Matricardi
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

4.  Population growth and allergen accumulation of Dermatophagoides farinae cultured at 20 and 25 °C.

Authors:  Lakshmi Yella; Marjorie S Morgan; Larry G Arlian
Journal:  Exp Appl Acarol       Date:  2012-10-16       Impact factor: 2.132

5.  Interfaces between allergen structure and diagnosis: know your epitopes.

Authors:  Anna Pomés; Maksymilian Chruszcz; Alla Gustchina; Alexander Wlodawer
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

6.  The association of allergic sensitization patterns in early childhood with disease manifestations and immunological reactivity at 10 years of age.

Authors:  Véronique Schulten; April Frazier; Agustin Calatroni; Meyer Kattan; Leonard B Bacharier; George T O'Connor; Megan T Sandel; Robert A Wood; Lisa M Wheatley; Alkis Togias; Cynthia M Visness; Amy Dresen; James E Gern; Alessandro Sette
Journal:  Clin Exp Allergy       Date:  2019-05-29       Impact factor: 5.018

7.  Allergen content and in vivo allergenic activity of house dust mite extracts.

Authors:  Anne Casset; Rudolf Valenta; Susanne Vrtala
Journal:  Int Arch Allergy Immunol       Date:  2013-03-15       Impact factor: 2.749

8.  Purification and characterisation of the dimeric group 12 allergen from Blomia tropicalis heterologously expressed by Escherichia coli Top10F´.

Authors:  Eduardo Santos da Silva; Luis Gustavo Carvalho Pacheco; Antônio Márcio Santana Fernandes; Claudia Asam; Elisânia Fontes Silveira; Carina da Silva Pinheiro; Neuza Maria Alcantara-Neves
Journal:  Mol Biol Rep       Date:  2021-04-29       Impact factor: 2.316

Review 9.  Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.

Authors:  Angelika Tscheppe; Heimo Breiteneder
Journal:  Int Arch Allergy Immunol       Date:  2017-05-04       Impact factor: 2.749

10.  A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.

Authors:  Katharina Marth; Isabella Breyer; Margarete Focke-Tejkl; Katharina Blatt; Mohamed H Shamji; Janice Layhadi; Anna Gieras; Ines Swoboda; Domen Zafred; Walter Keller; Peter Valent; Stephen R Durham; Rudolf Valenta
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.